OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Total revenue for 2022 was approximately $2.6 millionBalance sheet strengthened by recently closed public offering with gross proceeds of $7.5 millionConference call to be held March... | March 29, 2023

Related Keywords

Vienna ,Wien ,Austria ,Ukraine ,Russia ,China ,Beijing ,Chinese ,Curetis Gmb ,Oliver Schacht ,Albert Weber ,Gene Panel ,International Number ,Foundation For Innovative New Diagnostics ,Nasdaq ,European Investment Bank ,Securities Exchange ,Opgen Investor Press Contact ,Technology Platform ,Opgen Inc ,Exchange Commission ,Edison Group ,Full Year ,Chief Financial Officer ,Beijing Clear Biotech ,Ares Genetics ,Innovative New Diagnostics ,Dial In Number ,United Statesa ,Curetis Gmbh ,Ares Genetics Gmbh ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Nasdaq Capital Market ,Gen Investor ,Press Contact ,Months Ended December ,Ended December ,Opgen ,Nc Stock Exchange ,News ,Information ,Press Release ,Total ,Revenue ,Or ,022 ,Gas ,Illionbalance ,Sheet ,Strengthened ,Y ,Ecently ,Closed ,Public ,Offering ,Ith ,Cross ,Proceeds ,F ,Illionconference ,Wall ,O ,E Opgn Us68373l4068 ,